MPMatthew C. Pertzborn

Matthew C. Pertzborn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthew C. Pertzborn has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Dawn Baker

    Division of Pediatric Pulmonology, Department of Pediatrics, College of Medicine

    2 shared publications
  • Leslie Hendeles

    Division of Pediatric Pulmonology, Department of Pediatrics, College of Medicine

    2 shared publications
  • Sreekala Prabhakaran

    Division of Pediatric Pulmonology, Department of Pediatrics, College of Medicine

    2 shared publications
  • Alexandra Milloff Butler

    University of Florida, Gainesville, FL, USA

    1 shared publication
  • Alicia Hardy

    University of Florida College of Medicine

    1 shared publication
  • Amit Agarwal

    Division of Pediatric Pulmonary and Sleep Medicine, University of Arkansas for Medical Sciences/Arkansas Children's Hospital, Little Rock, AR, USA

    1 shared publication

Latest Publications

  • Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease

    by Zena Ghazala, Matthew Pertzborn, Macey Feimster, Chary Akmyradov, Joana Mack, Suzanne Saccente, Ariel Berlinski

    Background: Lung disease is a major cause of morbidity and mortality in children with sickle cell disease (SCD), a condition that is more common in individuals of African American descent. Spirometry is utilized in monitoring lung health. Recently, the American Thoracic Society recommended the use of race‐neutral predictive equations. We aimed to evaluate how the use of race‐neutral equations may affect spirometry results and interpretation in children with SCD.Methods: This retrospective study included children aged 5–21 years with SCD followed at Arkansas Children's Hospital (01/01/2000–06/30/2023) who had completed at least one spirometry. Percent predictive (pp) and z‐score values were calculated using race‐adjusted and race‐neutral predictive equations. Absolute and relative differences were calculated. Percent of subjects with forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) with z‐score <‐1.645 and pp < 80%, and FEV1/FVC z‐score < −1.645 were compared. Severity of impairment based on z‐score was compared.Results: One hundred children completed 460 spirometries. Transitioning from race‐adjusted to race‐neutral equations resulted in [mean (SD)]: a decrease in ppFEV1 [−9.497% (2.8344)], FEV1 z‐score [−0.723 (0.2286)], ppFVC [−10.08% (3.3440)], FVC z‐score [−0.750 (0.2757)], FEV1/FVC z‐score [−0.057 (0.05461)], and an increase in ppFEV1/FVC [0.2785 (0.3921)]. Transitioning from race‐adjusted to race‐neutral equations resulted in an increase of impairment for FVC and FEV1 and a threefold increase in subjects with abnormal values.Conclusions: Adoption of race‐neutral reference equations resulted in a decrease in FEV1 and FVC values (z‐scores and percent predicted) and an increase in severity of impairment.


  • Open Access

    Spontaneous pneumothorax or no pneumothorax at all?

    by Barrett J. Burger, Matthew Pertzborn, Kevin Bielamowicz, Zena Ghazala

    Tweetable abstract Care of a simple pneumothorax in a paediatric patient is often anything but simple, and a refractory and complex pneumothorax requires thoughtful and deliberate carehttps://bit.ly/3NFAk9S

  • Impact of Post-Visit Outreach on Inhaled Corticosteroid Refill Persistence in Children and Young Adults With Asthma

    by Kelly C Patrick, Beverly J Spray, Matthew C Pertzborn

    BACKGROUND: Inhaled corticosteroids (ICSs) are a fundamental pillar of most regimens for long-term control of persistent asthma. Poor adherence to ICS medication is a common problem in the asthma population that can lead to poor asthma control. We hypothesized that conducting a follow-up telephone call after general pediatric clinic visits for asthma would improve refill persistence. METHODS: We conducted a prospective cohort analysis of pediatric and young adult subjects followed in our pediatric primary care clinic for asthma on ICS medication found to have poor ICS refill persistence. This cohort received a follow-up telephone outreach call 5−8 weeks after the clinic visit. The primary outcome measure was refill persistence with regard to ICS therapy. RESULTS: There were 289 subjects who met the inclusion criteria and did not meet any exclusion criteria for the study ( n = 131 in the primary cohort, n = 158 in the post-COVID cohort). The mean ICS refill persistence increased significantly for subjects in the primary cohort (39.4 ± 30.8% post intervention vs 32.4 ± 19.7% pre intervention) ( P = .02) but not in the post-COVID cohort (36.4 ± 25.6% post intervention vs 38.9 ± 21.0% pre intervention) ( P = .26). There was not a statistically significant change in hospitalizations after the intervention in either the primary or the post-COVID cohorts ( P = .08 and .07, respectively). Systemic corticosteroid courses and emergency department visits decreased significantly post intervention ( P = .01 and P = .004, respectively) in the primary group but not in the post-COVID group ( P = .75 and P = .16, respectively). CONCLUSIONS: These results suggest that telephone outreach after out-patient clinic visits for asthma may have short-term benefit in ICS refill persistence; however, the effect size was small.


  • Open Access

    Influence of intrathoracic vagotomy on the cough reflex in the anesthetized cat

    by Tabitha Y. Shen, Matthew C. Pertzborn, Melanie J. Rose, M. Nicholas Musselwhite, Paul W. Davenport, Donald C. Bolser


  • Open Access

    A term neonate with cyanosis with crying

    by Matthew C. Pertzborn, Markus S. Renno, Karen Lyons, Jordan Fett, Christopher W. Baird, Amit Agarwal

    Congenital short trachea can be associated with bronchial compression with associated symptoms of apnoea, cyanosis, increased work of breathing, and/or respiratory failure in infancy. Operative intervention should be considered in symptomatic cases.https://bit.ly/3gM6Vv9


  • Continuous Albuterol With Benzalkonium in Children Hospitalized With Severe Asthma

    by Matthew C. Pertzborn, Sreekala Prabhakaran, Mutasim Abu-Hasan, Dawn Baker, Samuel Wu, Yue Wu, Leslie Hendeles

    BACKGROUND AND OBJECTIVES: The albuterol dropper bottle used to prepare solutions for continuous nebulization contains the preservative benzalkonium chloride (BAC). BAC, by itself, has been shown to cause bronchospasm. We hypothesized that BAC would decrease the therapeutic efficacy of albuterol in patients with acute asthma exacerbations. METHODS: We performed a retrospective cohort study comparing the clinical outcomes of patients P value <.05 was considered significant. RESULTS: A total of 477 patients were included in the analysis (236 exposed to BAC and 241 controls). The duration of continuous nebulization was significantly longer in the BAC group than in the control group (median of 9 vs 6 hours; 15.7% required continuous nebulization compared to 5.8% of controls at 24 hours). The control group was 79% more likely to stop continuous nebulization at any particular point in time (hazard ratio 1.79; 95% confidence interval: 1.45 to 2.22; P < .001) and 43% more likely to stop additional respiratory support (hazard ratio 1.43; 95% confidence interval: 1.16 to 1.75; P < .001). CONCLUSIONS: BAC is a functional albuterol antagonist associated with a longer duration of continuous albuterol nebulization treatment and additional respiratory support, suggesting that preservative-free albuterol formulations are safer for use in continuous nebulization.


  • Direct Observed Therapy of Inhaled Corticosteroids for Asthma at School or Daycare

    by Matthew C. Pertzborn, Sreekala Prabhakaran, Alicia Hardy, Dawn Baker, Matthew A. Robinson, Leslie Hendeles

    Background: Poor adherence with inhaled corticosteroid (ICS) medication is common in the pediatric population and can result in poor asthma control with increased frequency of asthma-related complications. The purpose of this study was to determine whether or not the initiation of ICS administration twice per day at school/daycare in patients with poor medication adherence at home improves asthma health care outcomes. Methods: We retrospectively selected patients followed by our Pediatric Pulmonology Clinic who had poorly controlled asthma and had been assigned to receive ICS twice daily at school/daycare due to poor adherence with ICS therapy. We analyzed the number of short courses of oral corticosteroids, hospital admissions, emergency department visits, and intramuscular methylprednisolone administrations for asthma exacerbations for the year before and after the intervention. The Wilcoxon signed rank test with continuity correction was used in the primary analysis. Results: Forty-nine patients who met the inclusion criteria were identified, but only 40 actually started the intervention. The number of oral corticosteroid courses per year decreased from 1.35 ± 1.1 before the intervention to 0.68 ± 1.2 ( P = 0.008) postintervention, hospital admissions per year decreased from 0.45 ± 0.7 to 0.10 ± 0.3 ( P = 0.006), emergency department visits per year decreased from 0.55 ± 0.8 to 0.28 ± 0.6 ( P = 0.084), and intramuscular repository methylprednisolone injections per year for asthma exacerbations decreased from 0.20 ± 0.4 to 0.10 ± 0.3 ( P = 0.23). Conclusion: These results indicate that school/daycare administration of ICS may be an effective option to improve indicators of asthma exacerbations in children with poor adherence to ICS at home.